LITS

0.83420.25%
JP

James P. Flynn

Independent Director

Mr. James P. Flynn, C.F.A. is Independent Director of Synlogic, Inc. from March 19, 2024. Mr. Flynn is Independent Director of RiceBran Technologies from January 2024. He serves as an Independent Director of Lite Strategy, Inc. (formerly known as MEI Pharma, Inc.) October 2023. He serves as an Independent Director of ARCA biopharma, Inc. since December 15, 2022. He also serves on the Board of Directors of Axiom Health (private). He is a Managing Member and Portfolio Manager of Nerium Capital LLC, an investment adviser he founded in 2021. Nerium Capital LLC is the General Partner of Nerium Partners LP, a healthcare focused investment Partnership. Mr. Flynn also serves as a Board Member for Axiom Health since 2022 and has been its advisor since 2020. From 2017 to 2018, Mr. Flynn worked as a therapeutics Analyst at Aptigon Capital (a Citadel Company), an investment firm. Prior to that, from 2003 to 2017, Mr. Flynn served in various roles at Amici Capital, LLC, an investment firm, including healthcare portfolio Manager (2008 to 2017). From 2002 to 2003, Mr. Flynn worked in the credit research/high yield group at Putnam Investments, an investment firm. He has experience as an Investor in life sciences companies, an Analyst for investment firms and has academic background. Mr. Flynn earned a S.B. degree in Management Science with a concentration in Finance and a minor in Economic Science from the Massachusetts Institute of Technology (MIT). Mr. Flynn is a Chartered Financial Analyst (CFA) Charterholder.

Positions